About Divis Laboratories
Divis Laboratories is a company based in Hyderabad (India) founded in 1990 by Murali K Divi. The company has 18,300 employees. Divis Laboratories offers products and services including Naproxen, Dextromethorphan, Gabapentin, Beta Carotene, and Vitamin D3. Divis Laboratories operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 18,300
- Founders Murali K Divi
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website divislabs.com
- Social LinkedIn X Facebook
- Legal Name Divi's Laboratories Limited
- Annual Revenue₹11,067 Cr
FY 2026 · +14% YoY
- Net Profit₹2,568 Cr
FY 2026 · 23% margin
- EBITDA₹3,874 Cr
FY 2026 · 35% margin
- Employee Count18,300
Associated legal entities of Divis Laboratories
Divis Laboratories is associated with 2 registered companies on The Company Check; the primary company is Divi's Laboratories Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Divi's Laboratories Limited Listed CIN L24110TG1990PLC011854 | Active | 12 Oct 1990 | Hyderabad, Telangana | ₹11,067 Cr | 11,560 | 13 | View details |
| Avant Garde Ventures Llp CIN AAP-0056 | Active | 23 Apr 2019 | Hyderabad, Telangana | – | – | 2 | View details |
Products & Services of Divis Laboratories
Divis Laboratories offers a comprehensive portfolio of products and services, including Naproxen, Dextromethorphan, Gabapentin, Beta Carotene, and Vitamin D3.
Active ingredient for pain and inflammation relief medications
Cough suppressant used in respiratory treatments
Medication for nerve pain and seizures management
Antioxidant supplement for nutritional health
Essential vitamin for bone health and immunity
Board of directors of Divi's Laboratories Limited (Divis Laboratories)
Divi's Laboratories Limited is the primary company behind Divis Laboratories. The boards of the 2 registered companies of Divis Laboratories currently have 10 directors; the longest-serving is Murali Krishna Prasad Divi, appointed in 1990. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Murali Krishna Prasad Divi DIN 00005040 | Managing Director | 12 Oct 1990 | 35 yrs 11 mo | Divi's Laboratories Limited |
| Nimmagadda Venkata Ramana DIN 00005031 | Whole-time director | 01 Oct 1994 | 32 yrs | Divi's Laboratories Limited |
| Rameshbabu Venkata Nimmagadda DIN 07854042 | Director | 27 Jun 2017 | 9 yrs 3 mo | Divi's Laboratories Limited |
| Ganapaty Seru DIN 07872766 | Director | 22 Jul 2017 | 9 yrs 2 mo | Divi's Laboratories Limited |
| Sunaina Singh DIN 08397250 | Director | 28 Mar 2019 | 7 yrs 6 mo | Divi's Laboratories Limited |
| Motaparti Nilima DIN 06388001 | Designated Partner | 23 Apr 2019 | 7 yrs 5 mo | Avant Garde Ventures Llp, Divi's Laboratories Limited |
| Satchandra Kiran Divi DIN 00006503 | Designated Partner | 23 Apr 2019 | 7 yrs 5 mo | Avant Garde Ventures Llp, Divi's Laboratories Limited |
| Veerayya Chowdary Kosaraju DIN 08485334 | Director | 04 Jan 2020 | 6 yrs 9 mo | Divi's Laboratories Limited |
| Devendra Rao Sureddy DIN 10481393 | Whole-time director | 10 Feb 2024 | 2 yrs 8 mo | Divi's Laboratories Limited |
| Rajendra Kumar Premchand DIN 00895990 | Director | 25 May 2024 | 2 yrs 4 mo | Divi's Laboratories Limited |
People of Divis Laboratories
24 people are tracked at Divis Laboratories (13 in leadership, 11 in team); the tracked headcount is 18,300.
| Name | Role | Group |
|---|---|---|
| Founder & Managing Director | Leadership | |
N.V. Ramana | Executive Director | Leadership |
Madhusudana Rao Divi | Whole-Time Director, Projects | Leadership |
| Whole-Time Director & CEO | Leadership | |
Nilima Prasad Divi | Whole-Time Director, Commercial | Leadership |
Prakash Divi | Vice President, Sales & Marketing | Leadership |
Manoranjan Jasti | Chief Information Officer | Leadership |
Harshita Garapati | Assistant General Manager - Corporate Communications | Leadership |
Anirudh Nimmagadda | Head Of Nutraceuticals | Leadership |
Rama Chaganti | VP & Global Head Of Sales, Generics | Leadership |
Krishna Rao | Dy.General Manager | Leadership |
Jitendra Polavarapu | Asst General Manager | Leadership |
Doraswamy Naidu Ananthaneni | General Manager Sales And Marketing | Leadership |
Phani Kishore | Dgm-key Account Relationships | Team |
Sree Divya Veeramachaneni | Management Associate | Team |
Brendan Flaherty | Sales Manager | Team |
Dr. Tarak R Nadella | Manager | Team |
Anette Ruf | Customer Service Manager | Team |
Meka Madhusudhan | DGM | Team |
Sameer Gorrepati | Maintainace Engineer | Team |
4 more people are available in the full profile.
Complete people profiles for Divis Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Divis Laboratories
Divis Laboratories is a publicly listed company on the NSE with ticker symbol DIVISLAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date12 Mar 2003
- Listed onNSE: DIVISLAB
- Listed entityDivi's Laboratories Limited
- Exchange sectorHealth technology
- ISININE361B01024
- Share price₹9,340.00 (-0.22% on the day) · 2026-10-09
- Market capitalisation₹247,576 Cr
- Price to earnings84.8
- EPS (diluted, trailing year)₹110.18
- Dividend yield0.32%
- Volume (last session)378,861
Financials of Divis Laboratories
Figures of Divi's Laboratories Limited, the primary company behind Divis Laboratories, for FY 2026. Revenue was ₹11,067 Cr (+14% year on year). Net profit was ₹2,568 Cr (23% margin). EBITDA was ₹3,874 Cr (35% margin). Revenue has grown at a compounded annual rate of +11% over three years and +9% over five years.
- ₹11,067 CrRevenue · FY 2026 · +14% YoY
- ₹2,568 CrNet profit · 23% margin
- ₹3,874 CrEBITDA · 35% margin
- ₹53.09 CrPaid-up capital
- 11,560Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | ₹10,548 Cr | ₹2,568 Cr | ₹3,479 Cr |
| 2024 | ₹9,358 Cr | ₹2,191 Cr | ₹3,040 Cr |
| 2023 | ₹7,832 Cr | ₹1,600 Cr | ₹2,330 Cr |
| 2022 | ₹7,749 Cr | ₹1,823 Cr | ₹2,405 Cr |
| 2021 | ₹8,906 Cr | ₹2,960 Cr | ₹3,873 Cr |
Balance sheet, profit and loss, cash flow and ratios of Divi's Laboratories Limited are on its company page.
Detailed financial statements for Divis Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Divis Laboratories
Divis Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| nglfinechem.com | 1981 | Mumbai, India | – | 395 | CDMO specializing in multi stage organic synthesis of generic APIs and fine chemicals |
Detailed competitors of Divis Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Divis Laboratories
The website of Divis Laboratories (divislabs.com) receives about 13.8K visits a month.
- Monthly visits13.8K
▲ 18.3% vs previous month
Websites whose visitors overlap most with Divis Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
equitypandit.com | equitypandit.com | 100% | – | #152,942 | – |
| mycorporateinfo.com | 60% | – | #336,697 | View details |
Latest news on Divis Laboratories
Complete news archive for Divis Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Divis Laboratories
10 companies that operate in the same segment as Divis Laboratories (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Divis Laboratories
Divis Laboratories was founded in 1990.
Divis Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Divis Laboratories has 18,300 employees.
The primary company behind Divis Laboratories, Divi's Laboratories Limited, reported revenue of ₹11,067 Cr for FY 2026, up 14% year on year.
Divis Laboratories was founded in 1990 in Hyderabad, India, and operates as a contract manufacturer in the pharmaceutical sector. Synthesis of chiral compounds and protected amino acids is specialized in, along with custom services for APIs and advanced intermediates used in drug discovery. Alternate processes that avoid patent infringement are developed for APIs and intermediates. Operations focus on providing these services to support pharmaceutical development.
Divis Laboratories's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem.
Divis Laboratories offers Naproxen, Dextromethorphan, Gabapentin, Beta Carotene, and Vitamin D3.
Yes, Divis Laboratories is publicly traded on NSE under the ticker symbol DIVISLAB.
Divis Laboratories is associated with 2 legal entities: Divi's Laboratories Limited, Avant Garde Ventures Llp.
The legal entities of Divis Laboratories currently have 12 directors, including Motaparti Nilima, Satchandra Kiran Divi, Nimmagadda Venkata Ramana and others.